info@thesyl.se

Regulatory Affairs

The Regulatory Affairs team is dedicated to supporting client projects through every phase. We manage everything from initial clinical trial start-up activities to securing product registration, Marketing Authorization, and insurance reimbursement.

Our Regulatory Approach

Patient-centered

A patient-centered approach ensures that all our decisions and actions prioritize patient safety and the accessibility of healthcare products. This involves understanding patient needs, maintaining product safety through compliance, and aligning regulatory strategies to drive better patient health outcomes.

Collaborative

We are inherently collaborative, requiring ongoing communication with multiple stakeholders, including health authorities, clients, partners, and internal teams. Our collaborative approach guarantees that all parties work toward the specific regulatory goal of securing approval while maintaining high-quality standards.

Tailored solutions

We develop tailored solutions by customizing strategies to meet the unique regulatory requirements of each market, product, and client. This approach addresses the specific challenges presented by different therapies, countries, and regulatory environments, ensuring compliance and facilitating efficient regulatory approvals.

Data-driven

Our decision-making process is data-driven, integrating scientific, clinical, regulatory, and market data to support the approval process. By leveraging advanced analytics and generating actionable insights, our regulatory affairs team enhances submission strategies, ensures ongoing compliance, and drives continuous improvement across the product lifecycle.

Regulatory in Clinical Trials

  • Support in the preparation and compilation of regulatory documents.
  • Verifying that regulatory documents adhere to pertinent guidelines.
  • Submission to Ethics Committees (EC)
  • Submission to Competent Authorities (CA)
  • Follow up
  • Reports submission

Product Registration (Marketing Authorization)

  • Regulatory Strategy
  • Submission Plan Development
  • Dossier Compilation & Submission through
    • Abridged Procedure (AP)
    • National Procedure (NP)/Full National Assessment
    • Mutual Recognition Procedure (MRP)/Recognition

Technical & Scientific Writing

Our Technical & Scientific Writing services are built through close collaboration with regulatory, technical, and medical professionals. We produce high-quality documents that meet the stringent requirements of the biopharmaceutical industry, including Common Technical Documents (CTD), study protocols, safety reports (DSUR/PBRER, PSUR, PADER), and scientific publications. Our team ensures accuracy, clarity, and compliance, supporting clients' projects from inception to submission with attention to detail and a deep understanding of industry standards.

Regulatory Intelligence

THESYL offers comprehensive Regulatory Intelligence services for biopharmaceutical companies. We provide expert insights into regulatory landscapes, helping you navigate complex compliance requirements and anticipate regulatory changes. Our team ensures your projects align with current regulations and standards, optimizing your pathway to successful product development and market entry. Partner with us for informed decision-making and strategic regulatory planning tailored to your needs.

Partner with us in shaping Health Research and Innovation for Africa